» Articles » PMID: 32164563

Maternal Plasma Lipid Levels Across Pregnancy and the Risks of Small-for-gestational Age and Low Birth Weight: a Cohort Study from Rural Gambia

Overview
Publisher Biomed Central
Date 2020 Mar 14
PMID 32164563
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Sub-optimal maternal lipid levels during pregnancy may be implicated in the pathophysiological mechanisms leading to low birth weight (LBW) and small-for-gestational-age (SGA). We aimed to determine whether maternal lipid levels across pregnancy were associated with birth weight and the risks of LBW and SGA in rural Gambia.

Methods: This secondary analysis of the ENID trial involved 573 pregnant women with term deliveries. Plasma levels of total cholesterol (TC), high-density lipoprotein cholesterol (HDL-c), low-density lipoprotein cholesterol (LDL-c), and triglycerides (TG) were analyzed at enrolment (mean (SD) = 13.9 (3.3) weeks gestation), 20 and 30 weeks gestation as continuous variables and percentile groups. Regression models with adjustment for confounders were used to examine associations between gestational lipid levels and birth weight and the risks of LBW (birth weight < 2500 g) and SGA (<10th percentile INTERGROWTH-21ST for birth weight).

Results: There were 7.9% LBW and 32.5% SGA infants. At enrolment, every unit increase in HDL-c was associated with a 2.7% (P = 0.011) reduction in relative risk of LBW. At 20 weeks gestation, every unit increase in TC levels was associated with a 1.3% reduction in relative risk of LBW (P = 0.002). Low (<10th percentile) HDL-c at enrolment or at 20 weeks gestation was associated with a 2.6 (P = 0.007) and 3.0 (P = 0.003) times greater risk of LBW, respectively, compared with referent (10th─90th) HDL-c. High (>90th percentile) LDL-c at 30 weeks gestation was associated with a 55% lower risk of SGA compared with referent LDL-c (P = 0.017). Increased levels of TC (β = 1.3, P = 0.027) at 20 weeks gestation and of TC (β = 1.2, P = 0.006) and LDL-c (β = 1.5, P = 0.002) at 30 weeks gestation were all associated with higher birth weight.

Conclusions: In rural Gambia, lipid levels during pregnancy were associated with infant birth weight and the risks of LBW and SGA. Associations varied by lipid class and changed across pregnancy, indicating an adaptive process by which maternal lipids may influence fetal growth and birth outcomes.

Trial Registration: This trial was registered as ISRCTN49285450 on: 12/11/2009.

Citing Articles

Trimester-specific reference intervals for blood lipid levels and their associations with adverse pregnancy outcomes in Southeast China.

Yang L, Liu Z, Chen J, Miao C, Li Q, Chen J Lipids Health Dis. 2025; 24(1):68.

PMID: 39987069 PMC: 11846285. DOI: 10.1186/s12944-025-02494-w.


The impact of maternal serum biomarkers on maternal and neonatal outcomes in twin pregnancies: a retrospective cohort study conducted at a tertiary hospital.

Wu H, Yu L, Xie Z, Cai H, Wen C PeerJ. 2024; 12:e18415.

PMID: 39484218 PMC: 11526785. DOI: 10.7717/peerj.18415.


Body composition in second trimester is associated with dyslipidemia in third trimester.

Jiang M, Li M, Li Y, Yu L, Zheng Y, Jiang R Arch Gynecol Obstet. 2024; 310(1):171-179.

PMID: 38491293 DOI: 10.1007/s00404-024-07407-3.


Lipid profile in women of different ethnicity with gestational diabetes: Relationship with fetal growth.

Dalfra M, Burlina S, Ragazzi E, Pastrolin S, Sartore G, Lapolla A J Diabetes Investig. 2023; 15(3):355-363.

PMID: 38087914 PMC: 10906017. DOI: 10.1111/jdi.14124.


The associations of gestational weight gain and midpregnancy lipid levels with placental size and placental-to-birth weight ratio: findings from a chinese birth cohort study.

Zhang K, Jia X, Yu W, Cheng X, Li Y, Wang X BMC Pregnancy Childbirth. 2023; 23(1):725.

PMID: 37821857 PMC: 10568921. DOI: 10.1186/s12884-023-05991-x.


References
1.
Rebholz S, Burke K, Yang Q, Tso P, Woollett L . Dietary fat impacts fetal growth and metabolism: uptake of chylomicron remnant core lipids by the placenta. Am J Physiol Endocrinol Metab. 2011; 301(2):E416-25. PMC: 3154537. DOI: 10.1152/ajpendo.00619.2010. View

2.
Misra V, Trudeau S, Perni U . Maternal serum lipids during pregnancy and infant birth weight: the influence of prepregnancy BMI. Obesity (Silver Spring). 2011; 19(7):1476-81. DOI: 10.1038/oby.2011.43. View

3.
Risnes K, Vatten L, Baker J, Jameson K, Sovio U, Kajantie E . Birthweight and mortality in adulthood: a systematic review and meta-analysis. Int J Epidemiol. 2011; 40(3):647-61. DOI: 10.1093/ije/dyq267. View

4.
Boghossian N, Mendola P, Liu A, Robledo C, Yeung E . Maternal serum markers of lipid metabolism in relation to neonatal anthropometry. J Perinatol. 2017; 37(6):629-635. PMC: 5446273. DOI: 10.1038/jp.2017.22. View

5.
Rebholz S, Melchior J, Davidson W, Jones H, Welge J, Prentice A . Studies in genetically modified mice implicate maternal HDL as a mediator of fetal growth. FASEB J. 2017; 32(2):717-727. PMC: 6266630. DOI: 10.1096/fj.201700528R. View